<乌鸦传媒>Novel Biannual Antihypertensive Shows Potential for Combination Therapy Drug might be most effective with a diuretic, according to suggestive data from a phase II trial Apr 09, 2024
<乌鸦传媒>Radial Cath Kits Recalled; siRNAs for Lipid Lowering; Smartphone HF Detection Recent developments of interest in cardiovascular medicine Apr 09, 2024
<乌鸦传媒>Third-Generation PCSK9 Inhibitor Cuts Cholesterol With Single, Small, Monthly Shot Patient acceptance could be an advantage, researchers say Apr 09, 2024
<乌鸦传媒>Early Win for Preemptive Stents on Vulnerable Coronary Plaque Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial Apr 08, 2024
<乌鸦传媒>Self-Selection for Statin Appears Safe, Effective Nonprescription rosuvastatin pans out in a second trial Apr 08, 2024
<乌鸦传媒>Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina After ORBITA-COSMIC, Reducer device's mechanism of benefit remains unknown Apr 08, 2024
<乌鸦传媒>Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial HDL therapeutic failed to reduce risk of MI, stroke, or cardiovascular death in high-risk group Apr 08, 2024
<乌鸦传媒>Chelation Flops for Cardio Health After Heart Attack TACT2 trial fails to confirm benefits in subgroup that gained the most in initial trial Apr 08, 2024
<乌鸦传媒>Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients Standard medications losing appeal amid more modern heart attack treatments Apr 08, 2024
<乌鸦传媒>Antisense Drug Slashes High Triglycerides Two trials show promise in moderate and extreme elevations Apr 08, 2024
<乌鸦传媒>Wegovy Helps HFpEF Patients With Diabetes Mellitus Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
<乌鸦传媒>Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitor Yet empagliflozin gets a boost from a lower risk of total HF events in EMPACT-MI Apr 07, 2024
<乌鸦传媒>Cardiology's Bid to Defect From ABIM Plows Ahead Application to form a new board is in, and it could be operational as soon as 2025 Apr 07, 2024
<乌鸦传媒>Can Machine Learning Predict CVD Risk? Sleep-Related Benefits of Exercise Also in TTHealthWatch: molnupiravir in immunocompromised people with COVID Apr 06, 2024 podcast
<乌鸦传媒>ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MI Plus an update on the new cardiovascular board at Atlanta meeting Apr 04, 2024
<乌鸦传媒>Patient Stabs ED Worker; Campus Building Tied to Cancer; Your Gut and Heart Disease Health news and commentary from around the Web gathered by 乌鸦传媒 staff Apr 03, 2024
<乌鸦传媒>After Lariat LAA Ligater Disappoints in aMAZE, Is a Path Ahead Still Possible? Adjunctive LAA ligation did not help efficacy of catheter pulmonary vein isolation Apr 02, 2024
<乌鸦传媒>A Closer Look at the New Statin Therapy Guidelines for Patients With HIV Clinicians can use these recommendations to navigate primary CVD prevention efforts Apr 02, 2024
<乌鸦传媒>E-Cigarettes Tied to Heart Failure Association seen with heart failure with preserved ejection fraction Apr 02, 2024
<乌鸦传媒>FDA Approves TriClip; Fortified Eggs vs Cholesterol; Impella Maker Chided Recent developments of interest in cardiovascular medicine Apr 02, 2024
<乌鸦传媒>5 Dead and Over 100 Hospitalized From Recalled Japanese Health Supplements The government's health ministry warned the number of deaths could keep growing Apr 01, 2024
<乌鸦传媒>The Bizarre History of the Human Heart The past, present, and future of a most vital organ Mar 28, 2024
<乌鸦传媒>Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertension Biologic should arrive on pharmacy shelves before May Mar 27, 2024
<乌鸦传媒>Red Meat-CVD Link Questioned; Drone AEDs to Bystanders; OCT-FFR in One Step? Recent developments of interest in cardiovascular medicine Mar 26, 2024
<乌鸦传媒>Arnold Schwarzenegger's Surgery; Bird Flu in U.S. Milk; Light Pollution and Strokes Health news and commentary from around the Web gathered by 乌鸦传媒 staff Mar 26, 2024
<乌鸦传媒>Predicting Vasculitis Relapse? It's SNOT That Hard Sino-nasal symptoms markedly raise the risk, study suggests Mar 25, 2024
<乌鸦传媒>Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet Mar 25, 2024
<乌鸦传媒>Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication New indications supported by CLEAR Outcomes trial Mar 22, 2024
<乌鸦传媒>Concomitant SSRI and Oral Anticoagulant Use Tied to Major Bleeding Risk Patients taking both drugs should be closely monitored, researchers advised Mar 22, 2024
<乌鸦传媒>Most Popular DOAC Holds Its Own Against Edoxaban in Those Age 80 and Up Apixaban associated with fewer bleeds in observational cohort study Mar 22, 2024
<乌鸦传媒>Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
<乌鸦传媒>Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients News comes in the wake of FDA approval to reduce risk of heart attacks, stroke Mar 21, 2024
<乌鸦传媒>In Heart Failure, Thinking Care Will Be Unaffordable May Mean Poorer Outcomes Distress over high cost of treatment in a Chinese study was linked to survival, quality of life Mar 21, 2024
<乌鸦传媒>Heart Disease Outcomes Better When Anxiety, Depression Are Treated Benefits associated with psychotherapy, antidepressants seen in analysis of Medicaid records Mar 21, 2024
<乌鸦传媒>Novel Oral Antihypertensive Gets FDA's Blessing Aprocitentan becomes the first endothelin receptor antagonist for BP lowering Mar 20, 2024
<乌鸦传媒>Structural Heart Metrics Debut; Amenorrhea-CVD Link; Once-a-Day Antianginal? Recent developments of interest in cardiovascular medicine Mar 18, 2024
<乌鸦传媒>Delta-8 THC Use Common in Teens; New Drug-Coated Balloon for Blocked Stents Also in TTHealthWatch: new screening methods for colorectal cancer Mar 16, 2024 podcast
<乌鸦传媒>EHR Alerts Trigger Primary Care Clinics to Improve Hypertension Care in CKD Greater reduction in systolic BP over usual care in randomized trial Mar 15, 2024
<乌鸦传媒>Meth-Related Cardiomyopathy: Where the Biggest Clusters Are Innovative, targeted approaches sought out groups by age, sex, location Mar 14, 2024
<乌鸦传媒>LVAD Monitoring App Recall; ADHD Drug & CVD Risk; Value of ATTR Treatments? Recent developments of interest in cardiovascular medicine Mar 12, 2024
